Rita Nanda Selected Research

Rita Nanda Research Topics

Disease

71	Breast Neoplasms (Breast Cancer) 05/2024 - 02/2006
54	Neoplasms (Cancer) 12/2023 - 12/2005
28	Triple Negative Breast Neoplasms 05/2024 - 12/2008
15	Pathologic Complete Response 05/2023 - 05/2013
5	Disease Progression 01/2023 - 01/2018
4	Residual Neoplasm 10/2022 - 07/2016
3	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2013
2	Leukopenia 05/2021 - 09/2014
2	Fatigue 05/2021 - 01/2020
2	Diarrhea 05/2021 - 06/2020
2	Neutropenia 05/2021 - 01/2016
2	Brain Neoplasms (Brain Tumor) 10/2018 - 08/2014
2	Carcinoma (Carcinomatosis) 10/2017 - 02/2006
1	Microsatellite Instability 08/2022
1	Cardiotoxicity 02/2022
1	Left Ventricular Dysfunction 02/2022
1	Hyperglycemia 10/2021
1	Enteritis 10/2021
1	Posterior Leukoencephalopathy Syndrome 10/2021
1	Dizziness (Lightheadedness) 10/2021
1	Lactic Acidosis 10/2021
1	Mental Fatigue 10/2021
1	Premature Menopause 08/2021
1	Amenorrhea 08/2021
1	Infertility (Sterility) 08/2021

Drug/Important Bio-Agent (IBA)

19	Hormones (Hormone)IBA 12/2023 - 04/2011
15	Trastuzumab (Herceptin)FDA Link 12/2023 - 05/2007
12	Estrogen ReceptorsIBA 12/2023 - 12/2005
10	Immune Checkpoint InhibitorsIBA 03/2024 - 10/2017
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2016
8	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 09/2014
7	Capecitabine (Xeloda)FDA Link 05/2024 - 06/2016
7	Progesterone Receptors (Progesterone Receptor)IBA 12/2023 - 12/2005
7	human ERBB2 proteinIBA 12/2020 - 05/2007
6	Lapatinib (GW572016)FDA Link 01/2023 - 05/2013
5	NivolumabIBA 05/2024 - 10/2017
5	pembrolizumabIBA 01/2023 - 01/2016
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 05/2013
4	Ado-Trastuzumab EmtansineIBA 02/2022 - 01/2021
3	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 01/2018
3	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 05/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2006
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 08/2017
3	atezolizumabIBA 01/2020 - 10/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2008
3	Letrozole (Femara)FDA LinkGeneric 01/2020 - 05/2013
3	Estrogens (Estrogen)FDA Link 01/2020 - 09/2008
3	LigandsIBA 01/2019 - 09/2008
2	Messenger RNA (mRNA)IBA 12/2023 - 01/2023
2	Circulating Tumor DNAIBA 12/2023 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2023 - 02/2006
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
2	olaparibIBA 12/2021 - 12/2020
2	durvalumabIBA 12/2021 - 10/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 10/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 10/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 08/2014
2	enzalutamideIBA 01/2020 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2013
2	TOR Serine-Threonine KinasesIBA 01/2020 - 05/2013
2	veliparibIBA 08/2017 - 07/2016
2	Carboplatin (JM8)FDA LinkGeneric 08/2017 - 07/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2016 - 01/2016
2	Mifepristone (RU 486)FDA Link 01/2016 - 09/2014
2	Albumin-Bound Paclitaxel FDA Link 01/2016 - 06/2015
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016 - 09/2014
1	trebananibIBA 12/2023
1	InterferonsIBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	AndrogensIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	STA 9090IBA 12/2022
1	Conjugate VaccinesIBA 10/2022
1	GlycosphingolipidsIBA 10/2022
1	Globo-HIBA 10/2022
1	Immunoglobulin G (IgG)IBA 10/2022
1	Immunoglobulin M (IgM)IBA 10/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	pertuzumabIBA 11/2021
1	urelumabIBA 10/2021
1	cabiralizumabIBA 10/2021
1	ganitumabIBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	ASP4132IBA 10/2021

Therapy/Procedure

32	Therapeutics 12/2023 - 04/2011
25	Neoadjuvant Therapy 12/2023 - 05/2013
24	Drug Therapy (Chemotherapy) 03/2024 - 05/2007
9	Immunotherapy 03/2024 - 01/2016
3	Meditation 05/2024 - 01/2023
3	Massage (Zone Therapy) 05/2024 - 01/2023
3	Music Therapy 05/2024 - 01/2023
2	Investigational Therapies (Experimental Therapy) 12/2023 - 11/2021
1	Injections 08/2022